BIOMARIN PHARMACEUTICAL INC (BMRN) › Shareholders' EquityBIOMARIN PHARMACEUTICAL INC (BMRN) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2007: $187.73M2008: $276.68M2009: $322.19M2010: $717.26M2011: $773.05M2012: $1.02B2013: $1.34B2014: $1.53B2015: $2.40B2016: $2.77B2017: $2.81B2018: $2.97B2019: $3.12B2020: $4.10B2021: $4.27B2022: $4.60B2023: $4.95B2024: $5.66B2025: $6.09B$6.09B2007Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$6.09B+7.6%2024$5.66B+14.3%2023$4.95B+7.6%2022$4.60B+7.9%2021$4.27B+4.0%2020$4.10B+31.3%2019$3.12B+5.2%2018$2.97B+5.7%2017$2.81B+1.5%2016$2.77B+15.2%2015$2.40B+57.1%2014$1.53B+13.9%2013$1.34B+32.0%2012$1.02B+31.4%2011$773.05M+7.8%2010$717.26M+122.6%2009$322.19M+16.4%2008$276.68M+47.4%2007$187.73M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share